2.1. Participants and Study Design
metabolic syndrome
METABOLIC SYNDROME, TYPE 2 DIABETES
In a randomized, controlled study design, participants with acute SCI were randomly assigned into intervention or sham-control groups in a 1:1 ratio. 20 individuals (3 F and 17 M; 31 ± 9 years of age; 12 Comb-NMES and 8 controls) with SCI (injury levels: C4-L1 American Spinal Injury Association Impairment Scale (AIS) A–C), within 14 days of the injury, medically stable at the time of testing, with no history of metabolic syndrome and/or type 1 or type 2 diabetes, completed the study (participant characteristics displayed in 